Lane DP - Search Results

1

p53 is phosphorylated at the carboxyl terminus and promotes the differentiation of human HaCaT keratinocytes.

Paramio JM, Segrelles C, Laín S, Gómez-Casero E, Lane DP, Lane EB, Jorcano JL. Paramio JM, et al. Among authors: lane eb, lane dp. Mol Carcinog. 2000 Dec;29(4):251-62. doi: 10.1002/1098-2744(200012)29:4<251::aid-mc1007>3.0.co;2-o. Mol Carcinog. 2000. PMID: 11170263

2

A rapid antibody assay system for screening hybridoma cultures.

Lane DP, Lane EB. Lane DP, et al. Among authors: lane eb. J Immunol Methods. 1981;47(3):303-7. doi: 10.1016/0022-1759(81)90286-6. J Immunol Methods. 1981. PMID: 7037967

3

Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide derived from p16CDKN2/INK4A.

Fåhraeus R, Paramio JM, Ball KL, Laín S, Lane DP. Fåhraeus R, et al. Among authors: lane dp. Curr Biol. 1996 Jan 1;6(1):84-91. doi: 10.1016/s0960-9822(02)00425-6. Curr Biol. 1996. PMID: 8805225 Free article.

4

Cell-cycle arrest and inhibition of Cdk4 activity by small peptides based on the carboxy-terminal domain of p21WAF1.

Ball KL, Lain S, Fâhraeus R, Smythe C, Lane DP. Ball KL, et al. Among authors: lane dp. Curr Biol. 1997 Jan 1;7(1):71-80. doi: 10.1016/s0960-9822(06)00029-7. Curr Biol. 1997. PMID: 8999999 Free article.

5

Protein interactions at the carboxyl terminus of p53 result in the induction of its in vitro transactivation potential.

Mundt M, Hupp T, Fritsche M, Merkle C, Hansen S, Lane D, Groner B. Mundt M, et al. Oncogene. 1997 Jul 10;15(2):237-44. doi: 10.1038/sj.onc.1201174. Oncogene. 1997. PMID: 9244359

6

Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor molecule.

Fåhraeus R, Laín S, Ball KL, Lane DP. Fåhraeus R, et al. Among authors: lane dp. Oncogene. 1998 Feb 5;16(5):587-96. doi: 10.1038/sj.onc.1201580. Oncogene. 1998. PMID: 9482104

7

An inhibitor of nuclear export activates the p53 response and induces the localization of HDM2 and p53 to U1A-positive nuclear bodies associated with the PODs.

Laín S, Midgley C, Sparks A, Lane EB, Lane DP. Laín S, et al. Among authors: lane eb, lane dp. Exp Cell Res. 1999 May 1;248(2):457-72. doi: 10.1006/excr.1999.4433. Exp Cell Res. 1999. PMID: 10222137

8

SUMO-1 modification activates the transcriptional response of p53.

Rodriguez MS, Desterro JM, Lain S, Midgley CA, Lane DP, Hay RT. Rodriguez MS, et al. Among authors: lane dp. EMBO J. 1999 Nov 15;18(22):6455-61. doi: 10.1093/emboj/18.22.6455. EMBO J. 1999. PMID: 10562557 Free PMC article.

9

Accumulating active p53 in the nucleus by inhibition of nuclear export: a novel strategy to promote the p53 tumor suppressor function.

Laín S, Xirodimas D, Lane DP. Laín S, et al. Among authors: lane dp. Exp Cell Res. 1999 Dec 15;253(2):315-24. doi: 10.1006/excr.1999.4672. Exp Cell Res. 1999. PMID: 10585254 Review. No abstract available.

10

Effects on normal fibroblasts and neuroblastoma cells of the activation of the p53 response by the nuclear export inhibitor leptomycin B.

Smart P, Lane EB, Lane DP, Midgley C, Vojtesek B, Laín S. Smart P, et al. Among authors: lane eb, lane dp. Oncogene. 1999 Dec 2;18(51):7378-86. doi: 10.1038/sj.onc.1203260. Oncogene. 1999. PMID: 10602494

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

500 results

Search Page

Filters